Viral Vitalism

Source Library

Effects of semaglutide and tirzepatide on stimulant and opioid use disorder outcomes in real-world populations

NIDA Clinical Trials Network study page on semaglutide/tirzepatide and SUD outcomes.

GovernmentGovernment health research
Source type
Government
Access type
Official
Publisher
National Institute on Drug Abuse
Added
2026-06-19

Trust profile

91

Government health research

Publisher type
Government research
Bias profile
Low

Best used for

  • Research synthesis
  • Public-health context
  • Safety resources

Weak for

  • Primary endpoint extraction when a study is available

Used in Viral Vitalism

Claims supported

No reusable evidence claims are currently attached to this source.

Related studies

No structured study record is currently attached to this source.

Related sources

Topic tags

glp-1semaglutidetirzepatideopioid-use-disorderstimulant-use-disorderreal-world-evidence

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No miracle claims. Just better health signal.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.